Diverticulosis and diverticulitis are diseases that affect more than 110 million people in the western world. Over 3 million people get complex diverticulosis requiring secondary care.

With no alternatives today, many patients end up undergoing a hemicolectomy and living with a colostomy.
Minos is developing a system to treat this disease at routine colonoscopy in a simple, patient friendly outpatient procedure.

More than 3 million diagnostic laparoscopies are performed each year in the western world. By moving the access site from abdominal to a trans-urinary bladder access, Minos believes the first mass NOTES procedure will be diagnostic and simple therapeutic peritoneoscopy procedures. The utility of a flexible scope combined with the working channel will give the added benefit of single port, basic therapeutic procedures such as adhesiolysis.

The trans-bladder route offers many advantages of trans-gastric, or trans-colon for basic NOTES procedures.

Minos Medical believes that NOS technology and NOTES technology can be utilized to enhance many procedures that are assisted by laparoscopy today. By using NOS technology, the abdominal scars can be removed. Lap assisted vaginal hysterectomy is ideal to be assisted by NOTES technology to eliminate those abdominal scars.

This is a high volume procedure, that with the help of NOS technology, could see even greater adoption. The (NAVH) or Notes Assisted Vaginal Hysterectomy (tm) is currently under development by Minos Medical.

Laparoscopic cholecystectomy is one of the most common procedures performed today in the western world. Patient demand drove this procedure to become the number one laparoscopic procedure.

Minos Medical is developing a system that using standard ERCP techniques will allow ablation, neutralization and closing off the lumen of the gallbladder, all using NOS technology. The Choleblate procedure has the potential to change the way gallbladder disease is treated.

Upwards of 90 million Americans have detectable appendiceal disease which annually results in 450,000 acute appendectomies (800,000 in the western world).

Minos Medical is building upon the Appendoectomy devices to ablate, neutralize and seal the appendix via a colonoscope during the chronic phase of appendiceal disease or after cooling off the appendix.
Using existing diagnostic techniques, the goal is to treat appendiceal disease before ever reaching the life threatening acute phase.This has obvious clinical and health economic benefits.